Menopause supplements costing more than £400 a year ‘no better than cheap multivitamin’

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Financial Intelligence • Markets • World News • Independent Analysis
Published: 2026-09-30 • Permanent link

Lavish spending on menopause supplements has left many consumers feeling misled. According to a recent investigation by consumer watchdog Which?, several high-end supplements costing more than £400 a year are no better than a £22-a-year multivitamin. The study found that these supplements often fail to provide meaningful quantities of key nutrients, leaving women over 45 with little to no tangible benefits. The market reaction has been swift, with some companies facing calls for greater transparency and accountability.

Financially, the implications of this scandal are significant. Investors in these companies may see their shares plummet as consumers turn to more affordable alternatives. The broader economy could also be impacted, as the demand for these supplements drives up prices and reduces competition in the market. As a result, consumers may be forced to choose between their health and their wallet, a difficult decision that could have long-term consequences for their well-being.

The menopause supplement industry has been plagued by controversy in recent years. Since last quarter, several high-profile companies have faced criticism for their marketing practices and product claims. Experts argue that the industry's lack of regulation has created a culture of greed, where companies prioritize profits over people's health. The situation is not unique to the UK, as similar issues have been reported in other countries, including the US and Australia.

As the industry continues to grapple with the fallout from this scandal, several key factors will shape the future of menopause supplements. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has announced plans to introduce new guidelines for the industry, which could provide much-needed clarity and transparency. However, it remains to be seen whether these changes will be enough to restore consumer trust and confidence in the market.